A new article published in BIO Integration on Apr. 2 outlines recent advancements in ocular drug delivery systems for treating eye conditions. The publication describes how traditional methods such as eye drops often face obstacles including rapid drainage and low bioavailability.
This topic is important because effective drug delivery to the eye can significantly impact patient outcomes and comfort, especially for chronic or severe ocular diseases.
According to the article, scientists have developed ocular inserts using biocompatible materials like hydrogels, polymers, and biodegradable nanoparticles. These materials enable controlled release of medication, improved retention time on the eye's surface, and better penetration through the corneal barrier. Additionally, advances in contact lens technology have led to drug-loaded lenses that provide sustained medication delivery directly to the ocular surface by increasing retention time and therapeutic efficacy.
The report also highlights microneedle-based ocular delivery as a promising new approach. Open-hollow and biodegradable microneedles allow minimally invasive penetration into the sclera or cornea for high bioavailability with prolonged drug release. Incorporating smart polymers, nanotechnology, and 3D printing has further improved accuracy, patient comfort, and overall effectiveness of these treatments.
These developments represent a shift from conventional topical treatments toward long-acting therapies that offer both higher efficacy and greater patient comfort.
